[1] Roher AE, Kokjohn TA, Clarke SG, et al.APP/Aβ structural diversity and Alzheimer's disease pathogenesis[J]. Neurochem Int, 2017, 110: 1-13. DOI: 10.1016/j.neuint.2017.08.007. [2] Chen GF, Xu TH, Yan Y, et al.Amyloid beta: structure, biology and structure-based therapeutic development[J]. Acta Pharmacol Sin, 2017, 38(9):1205-1235. DOI: 10.1038/aps.2017.28. [3] 张赫,郑焱. β淀粉样蛋白级联假说相关的阿尔茨海默病发病机制及防治策略研究进展[J]. 中国医学科学院学报,2019,41(5):702-708. [4] Bjerke M, Engelborghs S.Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis[J]. J Alzheimers Dis, 2018, 62(3):1199-1209. DOI: 10.3233/JAD-170680. [5] Jessen F, Amariglio RE, van Boxtel M, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease[J]. Alzheimers Dement, 2014, 10(6): 844-852. DOI: 10.1016/j. jalz. 2014. 01. 001. [6] Villemagne VL, Burnham S, Bourgeat P, et al.Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study[J]. Lancet Neurol, 2013, 12(4):357-367. DOI: 10.1016/S1474-4422(13)70044-9. [7] 马莹娟. 富含黄酮的柿叶提取物对衰老及APP / PS1小鼠的脑保护作用及其机制[D]. 山东大学,2019. [8] 董一峰,张子龙,王志成,等. 橙皮素早期干预对APPswe/PS1dE9双转基因小鼠Aβ生成的影响[J]. 中国药理学与毒理学杂志,2019,33(6):430-431. [9] Olsson B, Lautner R, Andreasson U, et al.CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis[J]. Lancet Neurol, 2016, 15(7): 673-684. DOI: 10.1016/S1474-4422(16)00070-3. [10] Jankowsky JL, Fadale DJ, Anderson J, et al.Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase[J]. Hum Mol Genet, 2004, 13(2): 159-170. DOI: 10.1093/hmg/ddh019. [11] 高雅,王鲁宁,张红红. APP swe/PS1dE9双转基因阿尔茨海默病模型小鼠生物学特征[J]. 中华老年心脑血管病杂志,2015,17(1):106-108. [12] Mei X, Yang M, Zhu L, et al.Retinal Levels of Amyloid Beta Correlate with Cerebral Levels of Amyloid Beta in Young APPswe/PS1dE9 Transgenic Mice before Onset of Alzheimer's Disease[J]. Behav Neurol, 2020, 2020: 1574816. DOI: 10.1155/2020/1574816. [13] Soininen H, Solomon A, Visser PJ, et al.24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial[J]. Lancet Neurol, 2017, 16(12): 965-975. DOI: 10.1016/S1474-4422(17)30332-0. [14] 王延江,卜先乐. 阿尔茨海默病的防治研究进展[J]. 第三军医大学学报,2014,36(21):2153-2157. [15] 范春兰,唐民科. Aβ中枢及外周清除机制[J]. 生理科学进展,2016,47(2):139-143. [16] Yamazaki Y, Kanekiyo T.Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease[J]. Int J Mol Sci, 2017, 18(9) DOI: 10.3390/ijms18091965. [17] Campos CR, Kemble AM, Niewoehner J, et al.Brain Shuttle Neprilysin reduces central Amyloid-β levels[J]. PLoS One, 2020, 15(3): e0229850. DOI: 10.1371/journal. pone.0229850. [18] Nalivaeva NN, Zhuravin IA, Turner AJ.Neprilysin expression and functions in development, ageing and disease[J]. Mech Ageing Dev, 2020, 192:111363. DOI: 10.1016/j. mad. 2020. 111363. [19] Fukami S, Watanabe K, Iwata N, et al.Abeta-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Abeta pathology[J]. Neurosci Res, 2002, 43(1): 39-56. DOI: 10.1016/s0168-0102(02)00015-9. [20] 邵骏菁,张晓平,杨颖,等. 黄酮类化合物防治阿尔茨海默病的研究进展[J]. 中国药房,2020,31(24):3066-3072. [21] 董云芳,冯慧利,何瑛琨,等. 姜黄素对小鼠海马Aβ生成酶和降解酶的影响[J]. 北京中医药大学学报,2016,39(3):230-234. [22] 张子龙,王志成,董一峰,等. 橙皮素早期干预对APPswe/PS1dE9小鼠学习记忆能力及TLR2、NF-κB表达水平的影响[J]. 承德医学院学报,2020,37(3):188-191. |